Cholangiocarcinoma Foundation's Calendar of Events

unless otherwise stated, all times are in Eastern Time, UTC -4.

July 22, 2021  

Moving for the Cure


July 18, 2021   July 24, 2021  

Moving for the Cure

Moving for the Cure


July 18, 2021   July 24, 2021  

Moving for the Cure

Moving for the Cure


July 18, 2021   July 24, 2021  

Moving for the Cure

Moving for the Cure


July 18, 2021   July 24, 2021  

Moving for the Cure

Moving for the Cure


July 18, 2021   July 24, 2021  

Moving for the Cure

Webinar: An interesting new study at NCI: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Biliary Tract Carcinoma


July 22, 2021  

CCF Webinar Series
An interesting new study at NCI: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Biliary Tract Carcinoma
Thursday, July 22, 2021, at 4:00pm (EDT)

Presented by: Cecilia Monge, M.D., M.P.H., FACP.

Dr. Cecilia Monge specializes in first-in-human and early-phase clinical studies of gastrointestinal (GI) malignancies, including liver cancer, biliary tract cancer, colorectal cancer and pancreatic cancer.

Join us to learn about a new clinical trial at the National Cancer Institute.

Webinar: An interesting new study at NCI: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Biliary Tract Carcinoma

Moving for the Cure


July 18, 2021   July 24, 2021  

Moving for the Cure

Moving for the Cure


July 18, 2021   July 24, 2021  

Moving for the Cure